MKMutsumi Kioka

Mutsumi Kioka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mutsumi Kioka has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Kavita Batra

    Office of Research, Department of Medical Education, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, USA

    3 shared publications
  • Kavita Batra

    Department of Medical Education and Office of Research, Kirk Kerkorian School of Medicine at UNLV, University of Nevada, Las Vegas, NV 89102, USA

    2 shared publications
  • Vidhani Goel

    School of Public Health, University of Nevada, Las Vegas, Las Vegas, USA

    2 shared publications
  • Aditi Singh

    Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV 89106, USA

    1 shared publication
  • Alfredo Iardino

    Internal Medicine, Texas Tech University Health Science Center at the Permian Basin, Odessa, Texas, USA

    1 shared publication
  • Amrit Kooner

    Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV

    1 shared publication

Latest Publications

  • Open Access

    Probable Tigecycline‐Induced Acute Eosinophilic Pneumonia: A Case Report

    by Annette Eom, Mutsumi Kioka

    A 25‐year‐old man developed acute hypoxaemic respiratory failure after 21 days of tigecycline therapy for osteomyelitis caused by multidrug‐resistant organisms. Chest computed tomography demonstrated bilateral consolidations, ground‐glass opacities, interlobular septal thickening, small bilateral pleural effusions and mediastinal lymphadenopathy. Bronchoalveolar lavage (BAL) revealed marked eosinophilia (99%–100%) despite minimal peripheral eosinophilia. Alternative causes, including infectious, parasitic, autoimmune and other potential aetiologies, were carefully evaluated. Based on the temporal relationship with tigecycline exposure, marked BAL eosinophilia, exclusion of alternative causes and the overall clinical presentation, probable tigecycline‐induced acute eosinophilic pneumonia (AEP) was diagnosed. Tigecycline was discontinued, cefiderocol was initiated for concomitant multidrug‐resistant Acinetobacter baumannii , and systemic corticosteroid therapy was administered, followed by progressive clinical and radiographic improvement. Although the clinical response followed multiple simultaneous interventions and therefore does not establish causality, the overall findings support tigecycline as the probable causative agent. To our knowledge, this is the first reported case of probable tigecycline‐associated AEP. This case highlights the importance of considering AEP in patients who develop unexplained respiratory deterioration during tigecycline therapy and underscores the diagnostic value of BAL, particularly in the absence of marked peripheral eosinophilia.


  • Open Access

    Poor agreement between bioreactance and echocardiography during passive leg raising in patients with shock

    by Antonious Anis, Juliann Shih, Vidhani Goel, Kavita Batra, Irene Huang, Mutsumi J. Kioka

  • Open Access

    Reversible complete atrioventricular block in immune checkpoint inhibitor–associated triple-M overlap syndrome: a case report

    by Sonal Prasad, Michael Dicaro, Thomas Iida, Tina Frisch, Mutsumi Kioka

    Background: Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of advanced malignancies but are associated with rare and potentially life-threatening immune-related adverse events. Overlap syndromes involving myocarditis, myositis, and myasthenia gravis-referred to as Triple-M overlap syndrome-have been reported; however, reversible high-grade atrioventricular block remains uncommon. Case summary: A 74-year-old woman with advanced ovarian cancer treated with pembrolizumab presented with dyspnoea, myalgia, and right-sided ptosis 22 days after ICI therapy. Electrocardiography demonstrated ST-segment elevation in the anterior leads with markedly elevated high-sensitivity troponin. On the following day, persistent ST-segment elevation prompted evaluation for acute myocardial infarction, and coronary angiography revealed no obstructive coronary artery disease. The clinical course was complicated by sustained ventricular tachycardia followed by complete atrioventricular block requiring temporary transvenous pacing. Laboratory evaluation showed markedly elevated creatine kinase, and neurological findings were consistent with neuromuscular junction involvement. Immune-mediated Triple-M overlap syndrome was suspected, and high-dose corticosteroids and intravenous immunoglobulin were initiated. The patient demonstrated progressive clinical improvement, with resolution of arrhythmias and recovery of atrioventricular conduction. Discussion: This case highlights a rare presentation of ICI-associated Triple-M overlap syndrome complicated by reversible complete atrioventricular block. Immune-mediated conduction abnormalities may progress despite improving cardiac biomarkers, and early immunomodulatory therapy may enable reversibility of high-grade atrioventricular block.


  • Open Access

    Reversible junctional bigeminy in severe hyperkalemia: electrocardiographic and biochemical correlation: A case report

    by Amrit Kooner, Robert Luong, Mutsumi Kioka

    Rationale: Severe hyperkalemia is classically associated with peaked T waves, PR prolongation, and QRS widening. However, sustained bigeminal rhythms resulting from junctional escape are exceptionally rare. Detailed correlations between electrocardiographic (ECG) changes and serum potassium levels remain scarce in the literature. Patient concerns: A 54-year-old man with end-stage renal disease on maintenance hemodialysis presented with hypotension and bradycardia. Diagnoses: ECG revealed a striking bigeminal rhythm characterized by alternating supraventricular and junctional escape complexes, an uncommon arrhythmic manifestation of hyperkalemia. Laboratory testing showed a serum potassium level of 7.5 mmol/L. Interventions: The patient underwent emergent hemodialysis for rapid potassium removal and received standard supportive management for hyperkalemia. Outcomes: Following hemodialysis, serum potassium normalized to 3.7 mmol/L, and the bigeminal rhythm resolved completely, with restoration of normal sinus rhythm. Serial ECGs demonstrated dynamic and reversible conduction changes in parallel with biochemical correction. Lessons: This case highlights a rare but reversible presentation of junctional bigeminy secondary to hyperkalemia. Recognition of this distinctive ECG pattern – correlated with paired serum potassium values – can facilitate timely diagnosis and prevent unnecessary interventions.

  • Open Access

    Anti-dipeptidyl-peptidase-like protein-6 antibody-associated encephalitis masquerading as weight loss and confusion: a case report

    by Victoria Sefcsik, Paulette Rodriguez, Monica Makar, Magnus Chun, Rayeheh Bahar, Supriya Kairamkonda, Mutsumi Kioka

    Anti-Dipeptidyl-peptidase-like protein-6 (DPPX) antibody-associated encephalitis is a rare autoimmune condition that affects the central and enteric nervous systems. It often presents with neuropsychiatric symptoms, cerebellar ataxia, and gastrointestinal dysmotility, though clinical manifestations can vary widely. We report the case of a 38-year-old woman with psychiatric symptoms who developed severe cognitive impairment, seizures, and a profound weight loss of 100 pounds over one year. Her symptoms initially led to multiple psychiatric diagnoses and treatments, delaying recognition of the underlying autoimmune process. Ultimately, cerebrospinal fluid analysis revealed high-titer anti-DPPX antibodies (1:1000). Despite aggressive immunotherapy—including corticosteroids, plasmapheresis, IVIG, and rituximab—the patient’s condition deteriorated, and she died under hospice care. This case expands the known clinical spectrum of anti-DPPX encephalitis by documenting the most extreme reported case of weight loss associated with the disease. The prodromal presentation with isolated weight loss underscores the diagnostic challenges when neuropsychiatric symptoms emerge late. Our case highlights the importance of maintaining clinical suspicion for autoimmune encephalitis in patients with unexplained weight loss and neurocognitive decline. Profound, unexplained weight loss may be an early and under-recognized manifestation of anti-DPPX encephalitis. Early recognition and immunotherapy are critical, but the potential for rapid progression and relapse demands heightened clinical vigilance and further research into optimal treatment strategies.


  • Open Access

    Neurotoxic effects of scorpion envenomation, a video of nystagmus, dysmetria, and tongue fasciculations: a case report

    by Salman Mohammed, Erica Rae Herrera, Mutsumi Kioka

    Scorpion stings are common in rural areas worldwide, with most cases being benign. However, certain species, such as Centruroides in Southwestern USA, can cause severe neurotoxic envenomations. Neurotoxic symptoms, including nystagmus and ataxia, are well documented in pediatric cases but remain rare in adults. We present a rare case of neurotoxic scorpion envenomation in an adult. A 32-year-old Hispanic female with a history of anaphylaxis to bee venom presented to the emergency department (ED) following a scorpion sting. While sitting at home, she felt two stings on her posterior right thigh, identified and killed the scorpion, and went to the ED. On evaluation, the patient was alert and oriented (Glasgow Coma Scale score of 15). Her vital signs were stable, and laboratory results were unremarkable. The patient initially experienced localized pain at the sting site, followed by generalized heaviness, muscle twitching, dry mouth, tongue "fuzziness," and throat heaviness but no respiratory distress. Neurological examination revealed nystagmus, tongue fasciculations, and dysmetria, consistent with neurotoxic envenomation. She was treated with a tetanus-diphtheria-pertussis (Tdap) booster, normal saline, ondansetron, lorazepam, and Centruroides scorpion antivenom (ANASCORP®). Owing to her anaphylaxis history, she was closely monitored for hypersensitivity reactions. The patient had an uneventful recovery and was discharged after 2 days without neurological complications. Scorpion envenomations can lead to severe neurotoxic effects, even in adults, particularly with multiple stings or enhanced venom absorption. Early recognition of neurotoxic symptoms is crucial for prompt intervention with antivenom and supportive care, significantly improving patient outcomes. This case emphasizes the importance of considering neurotoxic envenomations in adult patients, even when pediatric cases are more common.


  • Open Access

    A prospective study on the precision of height data from electronic medical records in tidal volume calculation for lung-protective ventilation

    by Salman Bs Mohamed, Kavita BDS Batra, Nicole Bs Pang, Elliot Do Runge, Mutsumi John Kioka

    Lung-protective ventilation is now the norm for all patients, regardless of the presence of acute respiratory distress syndrome (ARDS), owing to the mortality associated with higher tidal volumes (TV). Clinicians calculate TV using recorded height from medical records and predicted body weight (PBW); however, the accuracy remains uncertain. Our study aimed to validate accurate TV settings for lung-protective ventilation by examining the correlation between the charted height and bedside measurements. In a single-center study, we compared PBW-based TV calculated from recorded height to PBW-based TV from measured height and identified factors causing height overestimation during charting. Our team measured patient height within 24 hours of admission using metal tape. TV calculated from recorded height (6–8 mL/kg PBW) was significantly larger (391.55 ± 65.98 to 522.07 ± 87.97) than measured height-based TV (162.62 ± 12.62 to 470.28 ± 89.64) (P < .01). In the height overestimated group, 57.7% were prescribed TV by healthcare provider, which was more than TV of 8 mL/kg of PBW, as determined by measured height. Negative predictors for height overestimation were male sex (OR: 0.45 [95% CI: 0.25–0.82]; P = .008) and presence of driver’s license information (OR: 0.45 [95% CI: 0.25–0.80]; P = .007), whereas Asian ethnicity was a positive predictor (OR: 4.34 [95% CI: 1.09–17.27]; P = .04). The height overestimation group had a higher in-patient mortality rate (38.5%) than the matched/underestimation group (20%) (P < .01). In stadiometer-limited hospitals, the PBW-based TV is overestimated using the recorded height instead of the measured height. In the group where heights were overestimated, over half of the patients received TV prescriptions from healthcare providers that surpassed the TV of calculated 8 mL/kg PBW based on their measured height. The risk factors for height overestimation include female sex, Asian ethnicity, and missing driver’s license data. Alternative height measurement methods should be explored to ensure precise ventilation settings and patient safety.


  • Open Access

    Comparing demographics, clinical characteristics, and hospital outcomes by vaccine uptake status: A single-institution cross-sectional study

    by Claire Xinning Do Chen, Paul Cabugao, Max Do Nguyen, Daniel Villegas, Kavita BDS Batra, Aditi Md Singh, Mutsumi Kioka

    Vaccination against Coronavirus disease 2019 (COVID-19) has been the cornerstone of reducing morbidity and mortality of this disease, as it has been shown to decrease the risk of viral transmission, severity of disease, hospitalization, and intubation. However, true understanding of its impact is skewed by heterogeneous vaccine administration due to lack of equitable access, vaccine hesitancy, and varying social determinants of health. Therefore, this study aims to identify groups that are less likely to be vaccinated and understand whether the resultant differences in vaccination rates affect morbidity and mortality in socially marginalized COVID-19 patients. A retrospective cohort analysis was performed on a randomized and stratified population of 939 COVID-19 patients from January 2021 to December 2021. Bivariate analysis and logistic regression were used to assess demographic and clinical characteristic trends in unvaccinated, partially vaccinated, and fully vaccinated groups. No one age (P = .21), gender (P = .9), race (P = .12), ethnicity (P = .09), or health insurance status (P = .13) group was more vaccinated than the other. Similarly, no subgroup was at increased odds of intubation (P = .08) or death. However, patients with all categories of comorbidities including cardiopulmonary disease (P = <.001, effect size .17), renal disease (P = <.001, effect size 0.138), metabolic disease (P = .04), and immunocompromised (P = .01) states were found to have significantly higher vaccination rates. Our study also shows that full vaccination protects against mortality and decreases the odds of intubation by 55% (adjusted odds ratio = 0.453, P value = .015) compared to no vaccination or partial vaccination. Findings from this study show an encouraging trend that sicker patients had higher rates of vaccination against COVID-19. This trend highlights the need for further identification of motivators that may be applied to vaccine-hesitant populations, which can help guide population-level policy, increase vaccination campaign yield, and reach for health equity.